American Society of Clinical Oncology

Founded in 1964, the American Society of Clinical Oncology is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.

Displaying 1–48 of 84 results

ASCO Guidelines Bundle

Last Updated: Dec 19, 2021

$ 662.95 Print Included Guidelines:

Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer
Adjuvant Therapy for Stage III Colon Cancer
Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer – Brain Metastases
Antiemetics
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression
Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy
Axilla Management in Early-Stage Breast Cancer
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
Biomarkers for Systemic Therapy in Metastatic Breast Cancer
Bone-Modifying Agents in Metastatic Breast Cancer
Bone-Modifying Agents in Multiple Myeloma
Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents
Cardiac Dysfunction - Prevention and Monitoring in Cancer Survivors
Cervical Cancer Prevention
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma
Chemotherapy-Naïve Castration-Resistant Prostate Cancer
Chronic Pain in Survivors of Adult Cancers
Clear Cell Renal Cell Carcinoma
Colorectal Cancer Biomarkers
Colorectal Cancer Early Detection
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
Diffuse Astrocytic and Oligodendroglial Tumors in Adults
Early-Stage Breast Cancer
Estrogen and Progesterone Receptor Testing in Breast Cancer
Exercise, Diet, and Weight Management During Cancer Treatment
Fertility Preservation
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer
Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy
HER2 Testing in Breast Cancer
Hormone Receptor–Positive Breast Cancer Adjuvant Endocrine Therapy
HR-Positive, HER2-Negative Metastatic Breast Cancer
Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy
Immune-related Adverse Events — CAR T-Cell Therapy
Initial Management of Noncastrate Advance, Recurrent, or Metastatic Prostate Cancer
Integrative Medicine for Pain Management in Oncology
Invasive Cervical Cancer
Laryngeal Cancer
Late-Stage Colorectal Cancer
Lung Cancer Surveillance After Definitive Curative-Intent Therapy
Malignant Pleural Mesothelioma
Management of Cancer Cachexia
Management of Dyspnea in Advanced Cancer
Management of Hereditary Breast Cancer
Management of Male Breast Cancer
Management of Osteoporosis
Management of Salivary Gland Malignancy
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Medication-Related Osteonecrosis of the Jaw
Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy
Metastatic Pancreatic Cancer
Molecular Biomarkers in Localized Prostate Cancer
Multiple Myeloma
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
Non-Small Cell Lung Cancer — Adjuvant Therapy for Completely Resected Stages I-IIIA
Optimum Imaging Strategies for Advanced Prostate Cancer
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy
Ovarian Masses and Treatment of Epithelial Ovarian Cancer
Palliative Care in the Global Setting
Pancreatic Cancer - Evaluating Susceptibility
PARP Inhibitors in the Management of Ovarian Cancer
Platelet Transfusion
Potentially Curable Pancreatic Adenocarcinoma
Prevention And Management Of Chemotherapy-Induced Peripheral Neuropathy In Survivors Of Adult Cancers
Salivary Gland Hypofunction and/or Xerostomia
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
Small Renal Masses
Somatic Genomic Testing for Metastatic or Advanced Cancer
Stage II Colon Cancer Adjuvant Therapy
Stage III Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer without Driver Alterations
Systemic Therapy for Advanced Hepatocellular Carcinoma
Systemic Therapy for Melanoma
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
Treatment for Brain Metastases
Treatment of Early-Stage Colorectal Cancer
Treatment of Locally Advanced Esophageal Carcinoma
Treatment of Metastatic Carcinoma and Myeloma of the Femur
Use of Endocrine Therapy for Breast Cancer Risk Reduction
Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
White Blood Cell Growth Factors